BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
-15.32%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.26B
AUM Growth
+$1.26B
(-18%)
Cap. Flow
-$28.8M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
45.22%
Holding
99
New
8
Increased
29
Reduced
26
Closed
14
Top Buys
Top Sells
| 1 |
Assertio
ASRT
|
$25.1M |
| 2 |
ALR
Alere Inc
ALR
|
$23.9M |
| 3 |
Heron Therapeutics
HRTX
|
$13M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$9.47M |
| 5 |
Verastem
VSTM
|
$7.92M |
Sector Composition
| 1 | Healthcare | 90.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGLT
26
DELISTED
Egalet Corporation
EGLT
| $15M | 0.83% |
1,134,750
+700,000
| +161% | +$9.23M |
|
|
ZGNX
27
DELISTED
Zogenix, Inc.
ZGNX
| $14.9M | 0.83% |
1,107,205
-9,630,440
| -90% | -$3.17M |
|
28
Amphastar Pharmaceuticals
AMPH
$1.37B
| $14.9M | 0.83% |
1,276,979
-140,977
| -10% | -$1.65M |
|
|
ATRS
29
DELISTED
Antares Pharma, Inc.
ATRS
| $14.4M | 0.8% |
8,475,000
+900,000
| +12% | +$1.53M |
|
30
Rigel Pharmaceuticals
RIGL
$710M
| $12.7M | 0.7% |
5,125,282
-751,470
| -13% | -$1.86M |
|
31
Catalyst Pharmaceutical
CPRX
$2.42B
| $12.6M | 0.7% |
4,183,177
| – | – |
|
|
HTWR
32
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $12.5M | 0.7% |
+239,675
| New | +$12.5M |
|
33
Iovance Biotherapeutics
IOVA
$800M
| $12.1M | 0.67% |
2,105,519
+293,100
| +16% | +$1.69M |
|
|
GNMX
34
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $12.1M | 0.67% |
1,545,306
+431,406
| +39% | +$3.37M |
|
|
QLTI
35
DELISTED
QLT Inc
QLTI
| $11.8M | 0.66% |
4,445,527
| – | – |
|
|
TRVN
36
DELISTED
Trevena, Inc.
TRVN
| $11.2M | 0.62% |
1,078,132
-331,021
| -23% | -$3.43M |
|
|
DSCI
37
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $11.1M | 0.62% |
2,362,104
+44,615
| +2% | +$210K |
|
|
PETX
38
DELISTED
Aratana Therapeutics, Inc.
PETX
| $11.1M | 0.62% |
1,309,865
+178,000
| +16% | +$1.51M |
|
|
RDHL
39
Redhill Biopharma
RDHL
$2.94M
| $10.7M | 0.6% |
829,906
+445,625
| +116% | +$5.76M |
|
|
SPNC
40
DELISTED
Spectranetics Corp
SPNC
| $10.6M | 0.59% |
+900,249
| New | +$10.6M |
|
|
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $10.2M | 0.57% |
295,700
-63,961
| -18% | -$2.2M |
|
|
PRTK
42
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $10.1M | 0.56% |
530,283
| – | – |
|
43
Ardelyx
ARDX
$1.57B
| $9.49M | 0.53% |
549,290
-100,000
| -15% | -$1.73M |
|
44
Arcturus Therapeutics
ARCT
$467M
| $9.41M | 0.52% |
1,557,106
-22,700
| -1% | -$137K |
|
|
CYNA
45
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $9.05M | 0.5% |
586,117
-292,000
| -33% | -$4.51M |
|
46
AtriCure
ATRC
$1.73B
| $8.84M | 0.49% |
403,519
-79,835
| -17% | -$1.75M |
|
|
RPTP
47
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $8.55M | 0.48% |
1,412,995
+93,112
| +7% | +$563K |
|
48
ADMA Biologics
ADMA
$4.03B
| $8.06M | 0.45% |
964,193
| – | – |
|
|
AMRN
49
Amarin Corp
AMRN
$311M
| $8.06M | 0.45% |
4,175,216
+650,000
| +18% | +$1.25M |
|
|
ELOS
50
DELISTED
Syneron Medical Ltd
ELOS
| $7.55M | 0.42% |
1,055,221
+50,000
| +5% | +$358K |
|